TGFB1 and neoplasm: Although Jurkat cells are a tumor cell line and TGF-β can act as a tumor growth factor, using Jurkat cells expressing a dominant-negative TGF-β receptor II (dnTβRII) as a control enables us to separate the tumor-promoting effects of TGF-β from its specific role in activating the TGF-βRII CAR.